Hunan Provincial Key Laboratory for the Prevention and Treatment of Ophthalmology and Otolaryngology Diseases with Chinese Medicine, Hunan University of Chinese Medicine, Hanpu Rd., Yuelu District, Changsha, 410208, Hunan, China.
Hunan Engineering Technological Research Center for the Prevention and Treatment of Otolaryngologic Disease and Protection of Visual Function with Chinese Medicine, Changsha, 410208, Hunan, China.
BMC Complement Med Ther. 2021 Apr 10;21(1):118. doi: 10.1186/s12906-021-03238-w.
Diabetic retinopathy (DR) has become a worldwide concern because of the rising prevalence rate of diabetes mellitus (DM). Despite much energy has been committed to DR research, it remains a difficulty for diabetic patients all over the world. Since apoptosis of retinal microvascular pericytes (RMPs) is the early characteristic of DR, this study aimed to reveal the mechanism of Shuangdan Mingmu (SDMM) capsule, a Chinese patent medicine, on oxidative stress-induced apoptosis of pericytes implicated with poly (ADP-ribose) polymerase (PARP) / glyceraldehyde 3-phosphate dehydrogenase (GAPDH) pathway.
Network pharmacology approach was performed to predict biofunction of components of SDMM capsule dissolved in plasma on DR. Both PARP1 and GAPDH were found involved in the hub network of protein-protein interaction (PPI) of potential targets and were found to take part in many bioprocesses, including responding to the regulation of reactive oxygen species (ROS) metabolic process, apoptotic signaling pathway, and response to oxygen levels through enrichment analysis. Therefore, in vitro research was carried out to validate the prediction. Human RMPs cultured with media containing 0.5 mM hydrogen oxide (HO) for 4 h was performed as an oxidative-damage model. Different concentrations of SDMM capsule, PARP1 inhibitor, PARP1 activation, and GAPDH inhibitor were used to intervene the oxidative-damage model with N-Acetyl-L-cysteine (NAC) as a contrast. Flow cytometry was performed to determine the apoptosis rate of cells and the expression of ROS. Cell counting kit 8 (CCK8) was used to determine the activity of pericytes. Moreover, nitric oxide (NO) concentration of cells supernatant and expression of endothelial nitric oxide synthase (eNOS), superoxide dismutase (SOD), B cell lymphoma 2 (BCL2), vascular endothelial growth factor (VEGF), endothelin 1 (ET1), PARP1, and GAPDH were tested through RT-qPCR, western blot (WB), or immunocytochemistry (ICC).
Overproduction of ROS, high apoptotic rate, and attenuated activity of pericytes were observed after cells were incubated with media containing 0.5 mM HO. Moreover, downregulation of SOD, NO, BCL2, and GAPDH, and upregulation of VEGFA, ET1, and PARP1 were discovered after cells were exposed to 0.5 mM HO in this study, which could be improved by PARP1 inhibitor and SDMM capsule in a dose-dependent way, whereas worsened by PARP1 activation and GAPDH inhibitor.
SDMM capsule may attenuate oxidative stress-induced apoptosis of pericytes through downregulating PARP expression and upregulating GAPDH expression.
糖尿病视网膜病变(DR)由于糖尿病(DM)的患病率不断上升而成为全世界关注的问题。尽管人们在 DR 研究上投入了大量精力,但它仍然是全世界糖尿病患者的难题。由于视网膜微血管周细胞(RMPs)的凋亡是 DR 的早期特征,因此本研究旨在揭示中药双丹明目胶囊(SDMM 胶囊)对多聚(ADP-核糖)聚合酶(PARP)/甘油醛 3-磷酸脱氢酶(GAPDH)途径氧化应激诱导的周细胞凋亡的作用机制。
采用网络药理学方法预测 SDMM 胶囊溶解在血浆中的成分对 DR 的生物功能。通过蛋白质-蛋白质相互作用(PPI)的核心网络分析发现,PARP1 和 GAPDH 均参与其中,并参与了许多生物过程,包括对活性氧(ROS)代谢过程、凋亡信号通路和氧水平的反应的调节。因此,进行了体外研究以验证预测。用含有 0.5mmol/L 过氧化氢(HO)的培养基培养人 RMPs4 小时,建立氧化损伤模型。用不同浓度的 SDMM 胶囊、PARP1 抑制剂、PARP1 激活剂和 GAPDH 抑制剂与 N-乙酰-L-半胱氨酸(NAC)进行干预,以验证预测。采用流式细胞术检测细胞凋亡率和 ROS 表达,采用细胞计数试剂盒(CCK8)检测细胞活力,采用逆转录定量聚合酶链反应(RT-qPCR)、Western blot(WB)或免疫细胞化学(ICC)检测细胞上清液中一氧化氮(NO)浓度和内皮型一氧化氮合酶(eNOS)、超氧化物歧化酶(SOD)、B 细胞淋巴瘤 2(BCL2)、血管内皮生长因子(VEGF)、内皮素 1(ET1)、PARP1 和 GAPDH 的表达。
用含有 0.5mmol/L HO 的培养基孵育细胞后,观察到 ROS 过度产生、细胞凋亡率高和细胞活力下降。此外,本研究还发现,用 0.5mmol/L HO 孵育细胞后,SOD、NO、BCL2 和 GAPDH 下调,VEGFA、ET1 和 PARP1 上调,这些变化可以通过 PARP1 抑制剂和 SDMM 胶囊剂量依赖性地改善,而 PARP1 激活剂和 GAPDH 抑制剂则使其恶化。
SDMM 胶囊可能通过下调 PARP 表达和上调 GAPDH 表达来减轻氧化应激诱导的周细胞凋亡。